Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet’s Gilead Sciences GILD Stock Holding History

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-28,434	Closed	-$1.85M	–	67
2020 Q1	$1.85M	Hold	28,434	–	–	0.44%	53
2019 Q4	$1.85M	Hold	28,434	–	–	0.43%	55
2019 Q3	$1.92K	Hold	28,434	–	–	0.3%	53
2019 Q2	$1.92M	Buy	+28,434	New	+$1.87M	0.54%	48
2019 Q1	–	Sell	-28,434	Closed	-$1.78M	–	58
2018 Q4	$1.78M	Hold	28,434	–	–	0.57%	46
2018 Q3	$2.09M	Hold	28,434	–	–	0.69%	33
2018 Q2	$2M	Hold	28,434	–	–	0.75%	26
2018 Q1	$2.1M	Buy	28,434 +12,805	+82%	+$1.02M	0.77%	24
2017 Q4	$1.12M	Buy	+15,629	New	+$1.19M	0.45%	22

Other funds holding GILD

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet's GILD Position: Q2 2020 in Review

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet sold out of Gilead Sciences (GILD) in Q2 2020, closing a stake of 28,434 shares — an estimated $1.85M sold.

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet first reported a position in GILD in Q4 2017 and held it in 9 quarters. The position peaked at $2.1M in Q1 2018. 1,626 funds tracked by Wall St. Rank hold GILD as of Q2 2020.

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet reported no remaining Gilead Sciences position as of Q2 2020 after selling out during the quarter.
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet sold 28,434 Gilead Sciences shares in Q2 2020, an estimated $1.85M.
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet first reported a position in Gilead Sciences in Q4 2017 and held it in 9 quarters.
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet's Gilead Sciences position peaked at $2.1M in Q1 2018.
1,626 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2020.

Based on Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet's 13F filing for Q2 2020, filed 28 Jul 2020.